1. Home
  2. KPRX vs VRME Comparison

KPRX vs VRME Comparison

Compare KPRX & VRME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kiora Pharmaceuticals Inc.

KPRX

Kiora Pharmaceuticals Inc.

HOLD

Current Price

$2.75

Market Cap

10.7M

Sector

Health Care

ML Signal

HOLD

Logo VerifyMe Inc.

VRME

VerifyMe Inc.

HOLD

Current Price

$0.71

Market Cap

11.0M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
KPRX
VRME
Founded
1998
1999
Country
United States
United States
Employees
13
30
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
EDP Services
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
10.7M
11.0M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
KPRX
VRME
Price
$2.75
$0.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$10.00
$1.50
AVG Volume (30 Days)
50.9K
68.9K
Earning Date
05-08-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$36.85
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.76
$0.59
52 Week High
$3.78
$1.51

Technical Indicators

Market Signals
Indicator
KPRX
VRME
Relative Strength Index (RSI) 58.52 48.04
Support Level $2.57 $0.64
Resistance Level $2.94 $0.93
Average True Range (ATR) 0.14 0.04
MACD 0.01 0.01
Stochastic Oscillator 65.61 68.05

Price Performance

Historical Comparison
KPRX
VRME

About KPRX Kiora Pharmaceuticals Inc.

Kiora Pharmaceuticals Inc is a clinical-stage biotechnology company developing and commercializing products for the treatment of orphan retinal diseases. As part of its development, KIO-301 is being studied for the treatment of retinitis pigmentosa, choroideremia, and Stargardt disease. It is a molecular photoswitch that has the potential to restore vision in patients with inherited and/or age-related retinal degeneration. KIO-104 is being developed for the treatment of posterior non-infectious uveitis. It is a next-generation, non-steroidal, immuno-modulatory, and small-molecule inhibitor of dihydroorotate dehydrogenase.

About VRME VerifyMe Inc.

VerifyMe Inc is a logistics company that specializes in time and temperature-sensitive products, as well as providing brand protection and enhancement solutions. The company operates through two reportable business segments: Precision Logistics offers a value-added service provider for time and temperature-sensitive parcel management. Using a proprietary IT platform, it provides real-time information and analysis to mitigate supply chain flow interruption, delivering last-mile resolution for key markets, including the perishable healthcare and food industries; and the Authentication segment specializes in anti-counterfeit and brand protection. The Precision Logistics segment derives the majority of the revenue.

Share on Social Networks: